fashion -WSS

fashion

author：explore 2025-09-29 12:05:41 - browse：3397

a doctor wraps a smart watch around a patient's wrist — Adobe

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired HumanFirst, which helps companies answer exactly those sorts of questions.

Founded in 2017, HumanFirst maintains a meticulously organized library of digital measurement tools, their underlying evidence, and information about how they have been used in clinical trials. Called Atlas, the platform is designed so that a trial sponsor can research what tools are available to measure things like physical activity or sleep for many commonly studied diseases. CEO Andy Coravos said that robust intelligence can help developers move more quickly and avoid mistakes that require costly changes to trial protocols.

Following the acquisition, HumanFirst will be another offering for Icon, which earned $8 billion last year running clinical trials for pharmaceutical companies and other related services. As of 2021, HumanFirst had raised $15 million in venture capital funding, and the decision to sell to Icon for an undisclosed amount comes as some big drug companies are reevaluating their approach to digital technologies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Paxlovid should be available without a positive Covid test

hotspot

WSS

NIH chief: government has fallen behind pharma on clinical trials

After a drawn out lobbying fight, ARPA

Ionis has late

Weight loss drugs should be covered by insurers, AMA says

Cigna to pay $172 million to settle Medicare Advantage fraud probe

UnitedHealth sued over use of algorithm in Medicare Advantage plans

explore

fashion

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

Covid vaccines: Private market messier than government rollout

Continuity nursing helped my family in our darkest PICU moments

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Supreme Court strikes down use of affirmative action

Experimental asthma app from Apple and Anthem shows promise

Trump demands the U.S. pay no more for drugs than other countries … again

FDA advisers vote against ALS treatment from BrainStorm

United colonoscopy coverage change 'may cost lives,' doctors say

Why do women spend more than men on medical expenses?

hotspot

First transplant of an entire human eye performed

Today's health inequities arise from racist U.S. history, say experts

CVS, Rite Aid closures threaten to worsen pharmacy deserts

FDA seeks to regulate lab

Inequities make cancer less preventable for women: report

Ionis has late

entertainment

hotspot

hotspot

entertainment